Targeted Treatments of Non-Small Cell Lung Cancer: Skin Toxicity

    October 2022 in “ Дерматовенерология Косметология ”
    А.М. Лукьянов
    Studysummary This article reviews skin toxicity classifications and management in patients undergoing molecularly targeted therapy, noting significant dermatotropic side effects associated with Epidermal Growth Factor Receptor Inhibitors.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Dermatologic Reactions to Targeted Therapy Nursing Clinics of North America · 2017
    2. Immunolocalization of Epidermal Growth Factor Receptors in Normal Developing Human Skin Journal of Investigative Dermatology · 1990